impact:

Alirocumab in patients with heterozygous familial hypercholesterolaemia undergoing lipoprotein apheresis: the ODYSSEY ESCAPE trial

According to PR-model, Alirocumab in patients with heterozygous familial hypercholesterolaemia undergoing lipoprotein apheresis: the ODYSSEY ESCAPE trial is ranked 1,069,634^th in multilingual Wikipedia, in particular this website is ranked 62,164^th in German Wikipedia.

#Language

PR-model F-model AR-model

*All Wikipedias

1,069,634^th place

781,127^th place

937,233^rd place

deGerman

62,164^th place

21,644^th place

66,133^rd place